Lilly confirms date and conference call for second-quarter 2025 financial results announcement
Eli Lilly (NYSE:LLY) has scheduled its second-quarter 2025 financial results announcement for August 7, 2025. The company will host a conference call at 8:30 a.m. Eastern time to discuss the quarterly performance with investors, media, and the general public.
The event will be accessible through a live webcast via Lilly's investor relations website, with a replay available after the call.
Eli Lilly (NYSE:LLY) ha programmato l'annuncio dei risultati finanziari del secondo trimestre 2025 per il 7 agosto 2025. La società terrà una conference call alle 8:30 del mattino, ora Eastern per discutere le prestazioni trimestrali con investitori, media e pubblico generale.
L'evento sarà accessibile tramite una diretta streaming sul sito web delle relazioni con gli investitori di Lilly, con la possibilità di rivederlo in differita dopo la chiamata.
Eli Lilly (NYSE:LLY) ha programado el anuncio de sus resultados financieros del segundo trimestre de 2025 para el 7 de agosto de 2025. La compañía realizará una conferencia telefónica a las 8:30 a.m., hora del Este para analizar el desempeño trimestral con inversores, medios de comunicación y el público en general.
El evento será accesible a través de una transmisión en vivo en el sitio web de relaciones con inversores de Lilly, con una repetición disponible después de la llamada.
Eli Lilly (NYSE:LLY)는 2025년 2분기 재무 실적 발표를 2025년 8월 7일로 예정했습니다. 회사는 투자자, 언론 및 일반 대중과 분기 실적을 논의하기 위해 동부 표준시 오전 8시 30분에 컨퍼런스 콜을 진행할 예정입니다.
이 행사는 Lilly 투자자 관계 웹사이트를 통한 라이브 웹캐스트로 시청할 수 있으며, 콜 종료 후 다시보기 서비스도 제공됩니다.
Eli Lilly (NYSE:LLY) a programmé l'annonce de ses résultats financiers du deuxième trimestre 2025 pour le 7 août 2025. La société organisera une conférence téléphonique à 8h30, heure de l'Est pour discuter des performances trimestrielles avec les investisseurs, les médias et le grand public.
L'événement sera accessible via une diffusion en direct sur le site des relations investisseurs de Lilly, avec une rediffusion disponible après l'appel.
Eli Lilly (NYSE:LLY) hat die Bekanntgabe der Finanzergebnisse für das zweite Quartal 2025 für den 7. August 2025 geplant. Das Unternehmen wird um 8:30 Uhr Eastern Time eine Telefonkonferenz abhalten, um die Quartalsergebnisse mit Investoren, Medien und der Öffentlichkeit zu besprechen.
Die Veranstaltung ist über einen Live-Webcast auf der Investor-Relations-Website von Lilly zugänglich, mit einer Wiederholung, die nach dem Anruf verfügbar ist.
- None.
- None.
The conference call will begin at 8:30 a.m. Eastern time. Investors, media and the general public can access a live webcast of the conference call through a link that will be posted on Lilly's website at https://investor.lilly.com/webcasts-and-presentations. A replay will also be available on the website following the conference call.
About Lilly
Lilly is a medicine company turning science into healing to make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer's disease; providing solutions to some of the most debilitating immune system disorders; and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/news, or follow us on Facebook, Instagram, and LinkedIn. F-LLY
Trademarks and Trade Names
All trademarks or trade names referred to in this press release are the property of the company, or, to the extent trademarks or trade names belonging to other companies are references in this press release, the property of their respective owners. Solely for convenience, the trademarks and trade names in this press release are referred to without the ® and ™ symbols, but such references should not be construed as any indicator that the company or, to the extent applicable, their respective owners will not assert, to the fullest extent under applicable law, the company's or their rights thereto. We do not intend the use or display of other companies' trademarks and trade names to imply a relationship with, or endorsement or sponsorship of us by, any other companies.
Refer to: | Ashley Hennessey; gentry_ashley_jo@lilly.com; 317-416-4363 (Media) |
Michael Czapar; czapar_michael_c@lilly.com; 317-617-0983 (Investors) |
View original content to download multimedia:https://www.prnewswire.com/news-releases/lilly-confirms-date-and-conference-call-for-second-quarter-2025-financial-results-announcement-302512337.html
SOURCE Eli Lilly and Company
FAQ
When will Eli Lilly (LLY) report Q2 2025 earnings?
How can I access Eli Lilly's Q2 2025 earnings call?
Will there be a replay of Eli Lilly's Q2 2025 earnings call?
What time is Eli Lilly's Q2 2025 earnings call?
